Oragenics (OGEN) Stock Forecast, Price & News

Oragenics' stock was trading at $0.1051 at the start of the year. Since then, OGEN shares have increased by 2,535.6% and is now trading at $2.77.
View the best growth stocks for 2023 here.

Oragenics saw a decrease in short interest during the month of August. As of August 15th, there was short interest totaling 23,400 shares, a decrease of 23.8% from the July 31st total of 30,700 shares. Based on an average daily trading volume, of 10,000 shares, the short-interest ratio is currently 2.3 days. Approximately 1.0% of the shares of the company are sold short.
View Oragenics' Short Interest.

Oragenics, Inc. (NYSEAMERICAN:OGEN) issued its quarterly earnings results on Monday, August, 14th. The biotechnology company reported ($1.51) earnings per share (EPS) for the quarter. The biotechnology company earned $0.01 million during the quarter.

Oragenics's stock reverse split before market open on Monday, January 23rd 2023. The 1-60 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Oragenics investors own include Imunon (CLSN), Jaguar Health (JAGX), Biocept (BIOC), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Amarin (AMRN), Heat Biologics (HTBX), Idera Pharmaceuticals (IDRA) and Achieve Life Sciences (ACHV).

Oragenics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "OGEN."

Oragenics' stock is owned by a number of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (0.65%). Insiders that own company stock include Fred Telling, Joseph Hernandez, Michael O'keefe Sullivan and Robert C Koski.
View institutional ownership trends.

Shares of OGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OGEN stock can currently be purchased for approximately $2.77.

Oragenics (NYSEAMERICAN:OGEN) has a market capitalization of $7.04 million and generates $130,000.00 in revenue each year.

Oragenics' mailing address is 4902 Eisenhower Blvd Ste 125, TAMPA, FL 33634-6342, United States. The official website for the company is www.oragenics.com. The biotechnology company can be reached via phone at 813-286-7900, via email at johnm@coreir.com, or via fax at 813-286-7904.